From: Development of chronic lung impairment in Mozambican TB patients and associated risks
Characteristic | TB patients in final analysis (N = 62) |
---|---|
Sex | |
Male, % (n/N) | 67.74 (42/62) |
Age | |
Median (IQR) | 29.5 (25, 40) |
< 40 years old, % (n/N) | 74.19 (46/62) |
HIV-status | |
Positive, % (n/N) | 62.90 (39/62) |
CD4- cells < 200/μl, % (n/N) | 46.15 (18/39) |
CD4- cells < 300–499/μl, % (n/N) | 38.46 (15/39) |
CD4- cells ≥500/μl, % (n/N) | 15.38 (6/39) |
History of TB | |
Yes, % (n/N) | 6.45 (4/62) |
RIF resistance | |
Present, % (n/N) | 6.45 (4/62) |
Chronic respiratory diseasesa | |
Present, % (n/N) | 4.84 (3/62) |
Haemoglobin | |
Median male, g/dl (IQR) | 11.70 (10.2, 12.6) |
Median female, g/dl (IQR) | 9.90 (9.45, 11.00) |
Anaemiab | |
No, % (n/N) | 16.13 (10/62) |
Mild, % (n/N) | 37.10 (23/62) |
Moderate, % (n/N) | 41.94 (26/62) |
Severe, % (n/N) | 4.84 (3/62) |
C-reactive protein (CRP)b,c | |
Median, mg/dl (IQR) | 76.78 (44.0, 106.95) |
< 50 mg/dl, % (n/N) | 31.03 (18/58) |
51–100 mg/dl, % (n/N) | 39.66 (23/58) |
> 100 mg/dl, % (n/N) | 29.31 (17/58) |
BMIb | |
Median (IQR) | 19.23 (17.51, 20.50) |
< 18.5, % (n/N) | 41.94 (26/62) |
Culture conversion | |
until week 8 | 56.45 (35/62) |
until week 26 | 93.55 (58/62) |
Overall affected lungc | |
%, median (IQR) | 15 (15, 20) |
Smoking | |
Ever smoked, % (n/N) | 35.48 (22/62) |
Pack Yearsb, c | |
< 10 | 59.09 (13/22) |
≥ 10 | 31.82 (7/22) |
Alcohol consumptionb | |
Ever alcohol, % (n/N) | 77.42 (48/62) |
Amount of alcohol, median, g/week (IQR) | 80.0 (40, 240) |
Critical alcohol consumptionc, % (n/N) | 53.33 (32/60) |